We have located links that may give you full text access.
Benefits of early thymectomy in patients with myasthenia gravis.
European Journal of Surgery = Acta Chirurgica 1997 December
OBJECTIVE: To report our experience of early thymectomy in patients with myasthenia gravis.
DESIGN: Retrospective study.
SETTING: University department of surgery, Greece.
SUBJECTS: 76 Patients with myasthenia gravis.
INTERVENTIONS: Transcervical thymectomy in all cases, additional left thoracotomy in four cases.
MAIN OUTCOME MEASURES: Mortality, morbidity, and early (6 months) and late (mean follow-up 4.8 years) response to thymectomy.
RESULTS: 20 Patients had thymomas (26%). There was no postoperative mortality; morbidity was 11% (n = 8). There was complete remission in 19 (25%), improvement in 49 (65%) no change in 7 (9%), and impairment in 1 (1%) of the patients at 6 months. Patients who had had symptoms for less than 5 years (p < 0.001), were in an earlier stage of disease (p = 0.006), and who did not have thymomas (p = 0.006) responded better. 3 Patients died of invasive thymoma at 2 1/2, 3, and 5 1/2 years postoperatively and 25/76 (33%) were lost to follow-up. Of the 51 patients available for late follow-up, 19 (37%) were in remission, in 26 (51%) the symptoms had improved, 3 (6%) were unchanged, and 3 (6%) had died of the disease.
CONCLUSIONS: Transcervical thymectomy should be considered in patients with early myasthenia gravis.
DESIGN: Retrospective study.
SETTING: University department of surgery, Greece.
SUBJECTS: 76 Patients with myasthenia gravis.
INTERVENTIONS: Transcervical thymectomy in all cases, additional left thoracotomy in four cases.
MAIN OUTCOME MEASURES: Mortality, morbidity, and early (6 months) and late (mean follow-up 4.8 years) response to thymectomy.
RESULTS: 20 Patients had thymomas (26%). There was no postoperative mortality; morbidity was 11% (n = 8). There was complete remission in 19 (25%), improvement in 49 (65%) no change in 7 (9%), and impairment in 1 (1%) of the patients at 6 months. Patients who had had symptoms for less than 5 years (p < 0.001), were in an earlier stage of disease (p = 0.006), and who did not have thymomas (p = 0.006) responded better. 3 Patients died of invasive thymoma at 2 1/2, 3, and 5 1/2 years postoperatively and 25/76 (33%) were lost to follow-up. Of the 51 patients available for late follow-up, 19 (37%) were in remission, in 26 (51%) the symptoms had improved, 3 (6%) were unchanged, and 3 (6%) had died of the disease.
CONCLUSIONS: Transcervical thymectomy should be considered in patients with early myasthenia gravis.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app